Search tips
Search criteria 


Logo of neuroscibullNeuroscience Bulletin
Neurosci Bull. 2007 March; 23(2): 92–100.
Published online 2008 February 1. doi:  10.1007/s12264-007-0013-2
PMCID: PMC5550592

Language: English | Chinese

Facial pain induces the alteration of transient receptor potential vanilloid receptor 1 expression in rat trigeminal ganglion




To investigate the involvement of transient receptor potential vanilloid receptor 1 (TRPV1) in the facial inflammatory pain in relation to thermal hyperalgesia and cold pain sensation.


Facial inflammatory pain model was developed by subcutaneous injection of turpentine oil (TO) into rat facial area. Head withdrawal thermal latency (HWTL) and head withdrawal cold latency (HWCL) were measured once a day for 21 d after TO treatment using thermal and cold measurement apparatus. The immunohistochemical staining, cell-size frequency analysis and the survey of average optical density (OD) value were used to observe the changes of TRPV1 expression in the neurons of the trigeminal ganglion (TG), peripheral nerve fibers in the vibrissal pad, and central projection processes in the trigeminal sensory nuclei caudalis (Vc) on day 3, 5, 7, 14, and 21 after TO injection.


HWTL and HWCL decreased significantly from day 1 to day 14 after TO injection with the lowest value on day 5 and day 3, respectively, and both recovered on day 21. The number of TRPV1-labeled neurons increased remarkably from day 1 to day 14 with a peak on day 7, and returned back to the normal level on day 21. In control rats, only small and medium-sized TG neurons were immunoreactive (IR) to TRPV1, and the TRPV1-IR terminals were abundant in both the vibrissal pad and the Vc. Within 2 weeks of inflammation, the expression of TRPV1 in small and medium-sized TG neurons increased obviously. Also the TRPV1 stained terminals and fibers appeared more frequent and denser in both the vibrissal pad skin and throughout laminae I and the outer zone of laminae II (IIo) of Vc.


Facial inflammatory pain could induce hyperalgesia to noxious heat and cold stimuli, and result in increase of the numbers of TRPV1 positive TG neurons and the peripheral and central terminals of TG. These results suggest that the phenotypic changes of TRPV1 expression in small and medium-sized TG neurons and terminals might play an important role in the development and maintenance of TO-induced inflammatory thermal hyperalgesia and cold pain sensation.

Keywords: vanilloid receptors, facial pain, hyperalgesia, trigeminal ganglion



探讨辣椒素受体(transient receptor potential vanilloid receptor 1, TRPV1)参与和面部炎症痛相关的热痛觉过敏与冷痛觉感受的可能机制。


于大鼠面部皮下注射松节油造成面部炎症痛模型, 分别应用热测痛和冷测痛装置测量热缩头潜伏期(head withdrawal thermal latency, HWTL)和冷缩头潜伏期(head withdrawal cold lentency, HWCL)的变化, 每天测量一次, 连续21天。 应用免疫组织化学染色, 细胞大小频率分析和平均光密度值分析来研究面部炎症痛后第3、 5、 7、 14、 21天支配大鼠面部表皮区三叉神经节(trigeminal ganglion, TG)初级感觉神经元、 触须部皮肤末梢神经纤维和投射至三叉神经感觉尾侧亚核(trigeminal sensory nuclei caudalis, Vc)中枢突TRPV1表达的改变。


注射松节油后第1至14天, 热退缩反应潜伏期与冷退缩反应潜伏期均明显下降, 分别于注射后第5天和第3天达到最低, 第21天恢复到正常水平, 注射松节油后第1至14天, TRPV1表达的细胞数量增加, 并于第7天达到最大, 第21天恢复到正常水平。 正常大鼠TRPV1主要表达于TG 的中小神经元, 触须部皮肤以及三叉神经尾侧亚核含丰富的TRPV1 阳性末梢, 面部炎症痛后2周内, TG的中小神经元, 触须部皮肤末梢以及Vc的I和II外层均可见明显的TRPV1表达增加。


面部炎症痛可以引起大鼠对伤害性热刺激和冷刺激的痛觉过敏, 并导致三叉神经节中TRPV1阳性神经元和外周与中枢阳性神经纤维末梢数目增加, 表明TRPV1在三叉神经节的中小神经元和末梢轴突表型的改变可能对松节油引起面部炎症痛时热痛觉过敏和冷痛觉感受的形成与维持起重要作用。

关键词: 辣椒素受体, 面部痛, 痛觉过敏, 三叉神经节


[1] Caterina M.J., Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci. 2001;24:487–517. doi: 10.1146/annurev.neuro.24.1.487. [PubMed] [Cross Ref]
[2] Tominaga M., Julins D. Capsaicin receptor in the pain pathway. Jpn J Pharmacol. 2000;83:20–24. doi: 10.1254/jjp.83.20. [PubMed] [Cross Ref]
[3] Guo A., Vulchanova L., Wang J., Li X., Elde R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relation to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci. 1999;11:946–958. doi: 10.1046/j.1460-9568.1999.00503.x. [PubMed] [Cross Ref]
[4] Carlton S.M., Coggeshall R.E. Peripheral capsaicin receptors increase in the inflamed rat hindpaw: a possible mechanism for peripheral sensitization. Neurosci Lett. 2001;310:53–56. doi: 10.1016/S0304-3940(01)02093-6. [PubMed] [Cross Ref]
[5] Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 2000;288:306–313. doi: 10.1126/science.288.5464.306. [PubMed] [Cross Ref]
[6] Amaya F., Oh-hashi K., Naruse Y., Iijima N., Ueda M., Shimosato G., et al. Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons. Brain Res. 2003;963:190–196. doi: 10.1016/S0006-8993(02)03972-0. [PubMed] [Cross Ref]
[7] Zhou Y., Li G.D., Zhao Z.Q. State-dependent phosphorylation of epsilon-isozyme of protein kinase C in adult rat dorsal root ganglia after inflammation and nerve injury. J Neurochem. 2003;85:571–580. doi: 10.1046/j.1471-4159.2003.01675.x. [PubMed] [Cross Ref]
[8] Ji R., Samad T., Jin S., Schmoll R., Woolf C. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron. 2002;36:57–68. doi: 10.1016/S0896-6273(02)00908-X. [PubMed] [Cross Ref]
[9] Tominaga M., Wada M., Masu M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA. 2001;98:6951–6956. doi: 10.1073/pnas.111025298. [PubMed] [Cross Ref]
[10] Premkumar L.S., Ahern G.P. Induction of vanilloid receptor channel activity by protein kinase C. Nature. 2000;408:985–990. doi: 10.1038/35050121. [PubMed] [Cross Ref]
[11] Chuang H.H., Prescott E.D., Kong H., Shields S., Jordt S.E., Basbaum A.I., et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature. 2001;411:957–962. doi: 10.1038/35082088. [PubMed] [Cross Ref]
[12] Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–110. doi: 10.1016/0304-3959(83)90201-4. [PubMed] [Cross Ref]
[13] Jasmin L., Kohan L., Franssen M. The cold plate as a test of nociceptive behaviors: description and application to the study of chronic neuropathic and inflammatory pain models. Pain. 1998;75:367–382. doi: 10.1016/S0304-3959(98)00017-7. [PubMed] [Cross Ref]
[14] Simone D.A., Kajander K.C. Responses of cutaneous A fiber nociceptors to noxious cold. J Neurophysiol. 1997;77:2049–2060. [PubMed]
[15] Santos A.R., Calixto J.B. Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice. Neurosci Lett. 1997;235:73–76. doi: 10.1016/S0304-3940(97)00722-2. [PubMed] [Cross Ref]
[16] Kwak J.Y., Jung J.Y., Hwang S.W., Lee W.T., Oh U. A capsaicin-receptor antagonist, capsazepine, reduces inflammation-induced hyperalgesic responses in the rat: evidence for an endogenous capsaicin-like substance. Neuroscience. 1998;86:619–626. doi: 10.1016/S0306-4522(98)00012-8. [PubMed] [Cross Ref]
[17] Davis J.B., Gray J., Gunthorpe M.J., Hatcher J.P., Davey P.T., Overend P., et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature. 2000;405:183–187. doi: 10.1038/35012076. [PubMed] [Cross Ref]
[18] Ichikawa H., Sugimoto T. VR1-immunoreactive primary sensory neurons in the rat trigeminal ganglion. Brain Res. 2001;890:184–188. doi: 10.1016/S0006-8993(00)03253-4. [PubMed] [Cross Ref]
[19] Guan X.M. Medical Neurobiology. 1. Beijing: The People’s Medical Publishing House; 2002.
[20] Leem J.W., Willis W.D., Weller S.C., Chung J.M. Differential activation and classification of cutaneous afferents in the rat. J Neurophysiol. 1993;70:2411–2424. [PubMed]
[21] Beitel R.E., Dubner R. Response of unmyelinated (C) polymodal nociceptors to thermal stimuli applied to monkey’s face. J Neurophysiol. 1976;39:1160–1175. [PubMed]
[22] Hwang S.J., Valtschanoff J.G. Vanilloid receptor VR1-positive afferents are distributed differently at different levels of the rat lumbar spinal cord. Neurosci Lett. 2003;349:41–44. doi: 10.1016/S0304-3940(03)00750-X. [PubMed] [Cross Ref]

Articles from Neuroscience Bulletin are provided here courtesy of Springer